Researchers Design Small Molecule That Inhibits Pathology Associated With Myotonic Dystrophy Type 1

by Rajashri on  September 08, 2009 at 9:03 PM Research News
  •   Print
  •   Share
  •   Comments
  •  Text 
 Researchers Design Small Molecule That Inhibits Pathology Associated With Myotonic Dystrophy Type 1
A small molecule blocks an aberrant pathway associated with myotonic dystrophy type 1, the most common form of muscular dystrophy, has been designed by researchers at the University of Illinois.

The new compound, soon to be tested in cells, binds tightly to its target, an abnormally elongated RNA that hijacks part of the normal cellular machinery and brings on symptoms of the disease. The newly developed compound is the first to show high selectivity in binding the target while not disrupting other important RNA functions. The study appears this week in the Proceedings of the National Academy of Sciences.

Myotonic dystrophy type 1, a muscle degeneration disease that so far is untreatable, affects about one in 8,000 people worldwide. Some cases are mild, but others lead to a debilitating loss of muscle control, declines in organ function and other potentially life-threatening conditions.

Scientists have recently identified a primary causative agent of the disease, a mutant version of a gene, called DMPK, which contains an excessive number of tri-nucleotide repeats. Nucleotides are the chemical letters that spell out the sequence of a gene, and the normal version of the DMPK gene includes five to 34 cytosine-thymine-guanine (CTG) repeats. The mutant version of the gene includes 50 to as many as 10,000 CTG repeats.

"The longer the repeat the worse the disease and the earlier the onset of the disease," said U. of I. chemistry professor and department head Steven Zimmerman, who co-led the research with his colleague, chemistry professor Anne Baranger.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.

seanclancy(Guest)

10/10/2011

2009? Seriously, it's 2011 now - where is this technology and when can it be available? I'm an award winning guitarist diagnosed with MD 1 2 years ago. I can still play an electric guitar pretty good - but I can't play accoustic guitar anymore. I have 8000 million views on youtube from a video which was recorded when my symptoms were there but not affecting me as much. Cheers, Sean Clancy




X
  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Myotonic Dystrophy
Complete Medindia Resources
News Categories:  
Obesity Health Center

Research Related News

» Overgrowth of Bacteria in Gut Blamed For Irritable Bowel Syndrome » New Drug That Only Attacks Cancer Cells Developed
» Personality Traits Linked To Longevity in Centenarians » Lack of Vitamin D in Diet Raises Stroke Risk in Japanese-Americans
» Why Bovine TB Continues to Spread Demystified in New Research » Seaweed Pill May Help Treat Arthritis
» P. Aeruginosa Infection Leads to Worse Outcomes and Increased Hospitalizations in COPD Patients » Hormone Boosts Production of Molecules Which Fight Skin Infection
Read More >>